Dr. Nicole M. Schneiderman, MD

Dr. Schneiderman practices at Presence Resurrection Medical Center in Chicago, Illinois.

Dr. Schneiderman's NPI, 1871588111, was assigned on September 13, 2005. Dr. Schneiderman holds Illinois license 036105136.

Dr. Schneiderman's primary practice is Presence Resurrection Medical Center, at 7435 W Talcott Ave, Chicago, IL 60631 in Cook County. The practice phone is (773) 792-5253.

Dr. Schneiderman's primary practice is Presence Resurrection Medical Center in Chicago, Illinois. Dr. Schneiderman is also affiliated with Resurrection Medical Center. The medical group on file is Endeavor Health Medical Group. Dmand AI also links Dr. Schneiderman to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schneiderman practices, 4 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Schneiderman's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Schneiderman is licensed in Illinois.

CMS data shows 695 Medicare services from Dr. Schneiderman across 4 procedure codes in 2024, for 495 Medicare patients. Medicare paid $73,188 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 495 Medicare patients who saw Dr. Schneiderman in 2024. The largest group is 75 to 84, with 176 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 2.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schneiderman's median patient age at 62, with 55% women.

In 2024, Dr. Schneiderman wrote 60 Medicare Part D claims for 50 patients. 93% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $83 in total drug cost. In 2023, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Schneiderman for performance year 2024, reported as part of a group. Dr. Schneiderman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Dr. Schneiderman from 1 drug or device company in 2016. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $16.